DE3371514D1 - Thiazole derivatives, process for their preparation and pharmaceutical compositions containing them - Google Patents

Thiazole derivatives, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
DE3371514D1
DE3371514D1 DE8383301461T DE3371514T DE3371514D1 DE 3371514 D1 DE3371514 D1 DE 3371514D1 DE 8383301461 T DE8383301461 T DE 8383301461T DE 3371514 T DE3371514 T DE 3371514T DE 3371514 D1 DE3371514 D1 DE 3371514D1
Authority
DE
Germany
Prior art keywords
sub
sup
alkyl
aryl
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383301461T
Other languages
English (en)
Inventor
Richard Paul Pioch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE3371514D1 publication Critical patent/DE3371514D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194—Radicals derived from thio- or thiono carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Earth Drilling (AREA)
  • Inert Electrodes (AREA)
  • Treating Waste Gases (AREA)
DE8383301461T 1982-03-19 1983-03-16 Thiazole derivatives, process for their preparation and pharmaceutical compositions containing them Expired DE3371514D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/360,034 US4474794A (en) 1982-03-19 1982-03-19 N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds

Publications (1)

Publication Number Publication Date
DE3371514D1 true DE3371514D1 (en) 1987-06-19

Family

ID=23416322

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383301461T Expired DE3371514D1 (en) 1982-03-19 1983-03-16 Thiazole derivatives, process for their preparation and pharmaceutical compositions containing them

Country Status (22)

Country Link
US (1) US4474794A (de)
EP (1) EP0091220B1 (de)
JP (1) JPS58170773A (de)
KR (1) KR840004091A (de)
AT (1) ATE27156T1 (de)
AU (1) AU1254583A (de)
CA (1) CA1190547A (de)
CS (1) CS236788B2 (de)
DD (1) DD207376A5 (de)
DE (1) DE3371514D1 (de)
DK (1) DK91083A (de)
ES (1) ES520791A0 (de)
FI (1) FI830879L (de)
GB (1) GB2116973B (de)
GR (1) GR77882B (de)
IL (1) IL68152A0 (de)
NZ (1) NZ203605A (de)
PH (1) PH18504A (de)
PL (1) PL241066A1 (de)
PT (1) PT76397B (de)
RO (1) RO85385B (de)
ZA (1) ZA831882B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1277325C (en) * 1985-12-18 1990-12-04 Bruce A. Slomski Synthesis of nizatidine
ATE86619T1 (de) * 1987-04-06 1993-03-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von nitroethenderivaten.
NL9000132A (nl) * 1990-01-19 1991-08-16 Cedona Pharm Bv Nieuwe thiazoolderivaten.
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
PL241066A1 (en) 1985-01-02
EP0091220A2 (de) 1983-10-12
GB2116973B (en) 1985-08-29
IL68152A0 (en) 1983-06-15
AU1254583A (en) 1983-09-22
KR840004091A (ko) 1984-10-06
GB2116973A (en) 1983-10-05
CA1190547A (en) 1985-07-16
JPS58170773A (ja) 1983-10-07
FI830879L (fi) 1983-09-20
DK91083D0 (da) 1983-02-25
ATE27156T1 (de) 1987-05-15
PT76397A (en) 1983-04-01
PT76397B (en) 1986-02-04
FI830879A0 (fi) 1983-03-16
ZA831882B (en) 1984-11-28
EP0091220B1 (de) 1987-05-13
ES8405386A1 (es) 1984-06-01
PH18504A (en) 1985-08-02
DD207376A5 (de) 1984-02-29
EP0091220A3 (en) 1984-05-23
DK91083A (da) 1983-09-20
CS236788B2 (en) 1985-05-15
GR77882B (de) 1984-09-25
RO85385A (ro) 1984-11-25
GB8307201D0 (en) 1983-04-20
NZ203605A (en) 1985-10-11
US4474794A (en) 1984-10-02
RO85385B (ro) 1984-11-30
ES520791A0 (es) 1984-06-01

Similar Documents

Publication Publication Date Title
KR830007624A (ko) 헤테로 사이클릭 화합물의 제조방법
ES8605511A1 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
FI791908A (fi) 1-fenyl-2-aminoetanolderivat
RU2003127736A (ru) Ингибитора металлопротеиназ
ES383868A1 (es) Un procedimiento de preparar oxindolcarboxamidas.
EP0125803A3 (de) Pharmazeutisch aktive Dihydropyridine
DE3371514D1 (en) Thiazole derivatives, process for their preparation and pharmaceutical compositions containing them
EP0351385A3 (de) Amidino- und Guanidino-Derivate
ES8605796A1 (es) Procedimiento de preparacion de nuevos derivados de la quinoleina y sus sales de adicion con acidos apropiados
NZ194777A (en) N-aminoalkyl-n'-(2-chloroethyl)-n'-nitroso-ureas and pharmaceutical compositions
ATE27455T1 (de) Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
ES8609314A1 (es) Procedimiento pra la preparacion de 1,4-dihidropiridinas sustituidas,opticamente activas
ATE5586T1 (de) Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
GB1031165A (en) Guanidines, isoureas and isothioureas
ATE15796T1 (de) Benzhydrylsulfinylethylamine, verfahren zu deren herstellung und verwendung in der therapeutik.
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.
RU98109784A (ru) Фармацевтически активные производные хиназолина
FI850593L (fi) N-(2,6-disubstituerade aromatiska) -n'-pyridinylureafoereningar.
ES8604531A1 (es) Procedimiento para preparar pirido(1,4)benzodiazepinas
TH68407A (th) 3-ไพริดิล-4-แอริลพิร์โรลที่ถูกแทนที่ และวิธีการรักษาโรคและการป้องกันโรคที่เกี่ยวข้อง

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee